Latest News and Press Releases
Want to stay updated on the latest news?
-
STOCKHOLM, Sweden, July 24, 2003 (PRIMEZONE) -- The shareholders of Framfab AB (publ) are hereby invited to attend a special meeting of shareholders at 10 AM on Friday, August 8, 2003 at...
-
Bâle, 24 juillet 2003 - L'antagoniste de l'angiotensine-II Diovan® peut donc être utilisé non seulement dans le traitement de l'hypertension artérielle, mais aussi dans l'indication largement répandue...
-
Basel, 24 July 2003 - The decision by the Swiss Agency for Therapeutic Products (Swissmedic) means that Diovan®, an angiotensin II receptor blocker (ARB), can now be used not only for the treatment of...
-
Basel, 24 Juli 2003 - Diovan®, ein Angiotensin-II-Antagonist, kann somit nicht nur in der Behandlung des Bluthochdrucks sondern nun auch in der weit verbreiteten Indikation der Herzinsuffizienz...
-
For release content, please refer to the attachment....
-
For release content, please refer to the attachment....
-
Information for the press and financial analysts regarding the Belimo Group's semiannual report 2003
Belimo Group remains successful in spite of difficult market conditions Expressed in local currencies, sales increased by 3.3 percent. Net sales in Swiss francs declined during the first half of...
-
Die Belimo-Gruppe bleibt unter schwierigen Marktverhältnissen erfolgreich Der Umsatz in lokalen Währungen nahm um 3.3 Prozent zu. Der Nettoumsatz in Schweizer Franken bildete sich im ersten...
-
Le Groupe Belimo reste performant malgré les conditions difficiles du marché Le chiffre d'affaires en monnaies locales a augmenté de 3,3 pour cent, alors que le chiffre d'affaires net en...
-
For release content, please refer to the attachment....